Discontinuation of quetiapine from an NIMH-funded trial due to serious adverse events

Am J Psychiatry. 2009 Aug;166(8):937-8. doi: 10.1176/appi.ajp.2009.09040501.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Depressive Disorder, Major / drug therapy*
  • Depressive Disorder, Major / psychology
  • Dibenzothiazepines / adverse effects*
  • Dibenzothiazepines / therapeutic use
  • Humans
  • National Institute of Mental Health (U.S.) / statistics & numerical data
  • Quetiapine Fumarate
  • Randomized Controlled Trials as Topic / statistics & numerical data*
  • Regression Analysis
  • Research Support as Topic / statistics & numerical data
  • United States

Substances

  • Antipsychotic Agents
  • Dibenzothiazepines
  • Quetiapine Fumarate